Janssen Pharmaceutica NV

Beerse, Belgium
Purpose
to validate bedaquiline provisional breakpoints in order to support the WHO policy recommendations for the Bedaquiline Treatment Guideline for multidrug resistant tuberculosis
Grantee
Division
Global Health
Date
OCTOBER 2017
Region served
GLOBAL
Committed amount
$230,000
Grant topic
Tuberculosis
Duration (months)
15
Grantee location
Beerse, Belgium
Related work

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.